Life sciences firms see some fundraising success but need massive sums
Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.
Life Science & Biotech
Articles
Local life sciences, pharma consultancy acquired by German firm
Safis Solutions LLC, a 15-year-old Indianapolis consulting firm that helps life science companies move their products through the government regulatory process, has been acquired by PharmaLex, the companies announced Monday.
How Dow won fight to save key product
When Dow AgroSciences needed to battle a proposed federal ban on one of its most important products, it drafted an army—its farmers.
FDA issues warning to local doctor for breaking protocol on drug trial
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Medical device software firm plans to add 120 employees
Indianapolis-based software company Greenlight.guru has moved operations from one downtown facility to another to accommodate expansion.
FOCUS: Biosciences institute’s chief scientific officer aims to foster commercialization
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Startup that helps doctors direct-bill patients plans to add 64 workers
Freedom Healthworks, which expects to serve 12 physician practices with 6,000 patients by the end of the year, is relocating from Nora to downtown and tripling its office space.
High-tech compression garment maker lands FDA clearance
Fishers-based Recovery Force LLC took a big step this month toward its goal of bringing to market a wrap that’s designed to improve blood flow and enhance recovery for people battling serious health issues.
Purdue-based firm could change radiation treatments
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
Holcomb calls to use $500M fund from Toll Road lease to fund entrepreneurship
Gov.-elect Eric Holcomb, who announced his legislative agenda Thursday, has roughly the same idea as Gov. Mike Pence when it comes to investing in early-stage Indiana companies, but wants to pay for the plan through a different fund.
Lilly trims profit guidance but says growth strategy on track
The company’s announcement reassured investors in the wake of last month’s news that the Alzheimer’s drug solanezumab had failed to demonstrate effectiveness during a large-scale clinical trial.
At Eli Lilly, tears, heartbreak and renewed determination
Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn’t make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.
Anthem, Cigna to begin court fight to save $48 billion merger
Anthem Inc.’s proposed merger with Cigna Corp. would reduce health-care competition and raise costs for consumers, U.S. antitrust lawyers will argue Monday when the government goes to court to try to block the transaction.
Medical-equipment repair firm investing $1M, adding up to 31 jobs
Cryogenic Solutions Inc. is consolidating a recently acquired New York company into Indianapolis and doubling space at its S. Lynhurst Drive headquarters to accommodate it.
Dow-DuPont merger hits delays as EU demands missing deal info
Dow Agrosciences parent Dow Chemical Co. and DuPont Co. face further delays to their plans to create the world’s biggest chemical company
Dow Agro sales rise on strong demand for seeds
Indianapolis-based Dow AgroSciences said sales and operating earnings rose in the third quarter, thanks in part to strong demand for products in Latin America. Meanwhile, the massive merger between parent Dow Chemical and DuPont has been delayed.
Indy-based NICO works for acceptance of less invasive brain surgery tools
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Lilly’s Elanco unit buying pet-vaccine portfolio for $885M
The Indianapolis drugmaker's animal-health division is bulking up its companion-animal business by buying Boehringer Ingelheim International's U.S. feline, canine and rabies medications.
Indiana Biosciences Research Institute picks chief scientific officer
Rainer Fischer most recently served as senior executive director of the Fraunhofer Institute for Molecular Biology and Applied Ecology in Germany. The institute is part of the largest applied science research organization in Europe.
New firm focuses on innovations, including ‘ear in a dish’
In a Q&A, Monon Bioventures CEO Joe Trebley talks about the goals and ambitions of his one-year-old firm.